![](https://www.moreinamerica.com/wp-content/uploads/2021/08/MORE_logo_SCIENCE.png)
We invest in science to help improve the availability and safe delivery of medication.
Lindsey Thomas, Senior Vice President, Marketing, discusses how Fresenius Kabi Ready-to-Administer products are designed to help our customers in the areas of safety and ease of use.
![](https://www.moreinamerica.com/wp-content/uploads/2021/08/more_science_rfid.png)
![](https://www.moreinamerica.com/wp-content/uploads/2021/08/more_science_thumb1.jpg)
To streamline medication management from the pharmacy to the bedside, Fresenius Kabi offers Simplist® prefilled syringes and freeflex® premixed IV bags in multiple medications and standard strengths. [Read More]
![](https://www.moreinamerica.com/wp-content/uploads/2021/08/more_science_thumb2.jpg)
![](https://www.moreinamerica.com/wp-content/uploads/2021/08/more_science_thumb3.jpg)
We opened our first U.S. compounding facility in Canton, MA in 2018 with state-of-the-art manufacturing technology and processes designed to meet rigorous quality standards and the increased capacity needs of
customers. [Take a Tour]
1. GS1 US®. (2020). Case Study: Fresenius Kabi. https://www.gs1us.org/content/dam/gs1us/documents/industries-insights/case-studies/healthcare/Case-Study-Fresenius-Kabi.pdf. Accessed October 24, 2023, at plusrfid.com/products/.